Bausch + Lomb Corporation (BLCO) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Bausch + Lomb Corporation has announced FDA approval for its enVista Envy intraocular lens, designed to deliver a full range of vision with minimal disturbances. Clinical trials in the U.S. and Canada have shown high patient satisfaction and tolerance, with the product set to be available in the U.S. in a limited release soon and broadly in 2025.
For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.